Hepatic profile analyses of tipranavir in Phase II and III clinical trials

<p>Abstract</p> <p>Background</p> <p>The risk and course of serum transaminase elevations (TEs) and clinical hepatic serious adverse event (SAE) development in ritonavir-boosted tipranavir (TPV/r) 500/200 mg BID recipients, who also received additional combination antir...

Full description

Bibliographic Details
Main Authors:	Rockstroh Jürgen, Pol Stanislas, Dieterich Douglas, Benhamou Yves, Sulkowski Mark S, Mikl Jaromir, Robinson Patrick A, Ranga Mithun, Stern Jerry O
Format:	Article
Language:	English
Published:	BMC 2009-12-01
Series:	BMC Infectious Diseases
Online Access:	http://www.biomedcentral.com/1471-2334/9/203

Similar Items

FDA Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses In Vitro
by: Michal Stefanik, et al.
Published: (2020-06-01)

FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells
by: Michal Stefanik, et al.
Published: (2020-04-01)

Impact of first-line protease inhibitors on predicted resistance to tipranavir in HIV-1-infected patients with virological failure
by: Chen Mao-Yuan, et al.
Published: (2009-09-01)

Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands
by: Kappelhoff Bregt S, et al.
Published: (2007-11-01)

It Is Time for a Simplified Approach to Hepatitis B Elimination
by: Douglas Dieterich, et al.
Published: (2023-01-01)

Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach
by: Purushothaman Indu, et al.
Published: (2020-12-01)

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial.
by: David A Cooper, et al.
Published: (2016-01-01)

Distinct CD4+ CD8+ double-positive T cells in the blood and liver of patients during chronic hepatitis B and C.
by: Michelina Nascimbeni, et al.
Published: (2011-01-01)

Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype.
by: Hendy Abdoul, et al.
Published: (2008-01-01)

Managing antiretrovirals in co-infected patients in 2012
by: Rockstroh Jürgen
Published: (2012-05-01)

The path to hepatitis C elimination: who are we leaving behind and why?
by: Jurgen K. Rockstroh, et al.
Published: (2023-07-01)

Late presentation of chronic viral hepatitis for medical care: a consensus definition
by: Stefan Mauss, et al.
Published: (2017-05-01)

A Giant Hepatic Cyst Mimicking Echinococcosis
by: Leszek Sułkowski, et al.
Published: (2018-06-01)

HCV: is mission accomplished? The pros
by: Stanislas Pol
Published: (2016-05-01)

HCV cure for everyone or which challenges remain?
by: Jürgen Kurt Rockstroh
Published: (2015-04-01)

Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection
by: Rivière Yves, et al.
Published: (2012-03-01)

Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination.
by: Daniel Scott-Algara, et al.
Published: (2010-01-01)

Retinoic Acid: A New Old Friend of IL-17A in the Immune Pathogeny of Liver Fibrosis
by: Daria M. Kartasheva-Ebertz, et al.
Published: (2021-06-01)

Closed-loop insulin delivery: understanding when and how it is effective
by: Pierre-Yves Benhamou, et al.
Published: (2020-02-01)

Validation of the shortened Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS)
by: Maria Mattera, et al.
Published: (2018-11-01)

The Liver Meeting 2014: Summary of Presentations on Genotype 3 HCV Infection from the 65th Annual Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), Held in Boston, MA, USA, on 7th-11th November, 2014
by: Markus Peck, et al.
Published: (2015-01-01)

Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients.
by: Lars Peters, et al.
Published: (2013-01-01)

Grazoprevir/elbasvir combination therapy for HCV infection
by: Anaïs Vallet-Pichard, et al.
Published: (2017-01-01)

Assessing the impact on caregivers caring for patients with rare pediatric lysosomal storage diseases: development of the Caregiver Impact Questionnaire
by: Magdalena Harrington, et al.
Published: (2019-07-01)

Hepatitis E Virus Infection in Sheltered Homeless Persons, France
by: Mamadou Kaba, et al.
Published: (2012-06-01)

Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive Study
by: Lucia Parlati, et al.
Published: (2023-05-01)

Echanges thermiques des parois d’un environnement habitable: étude et analyse
by: A. Oudrane, et al.
Published: (2018-06-01)

Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study.
by: Axel J Schmidt, et al.
Published: (2011-03-01)

Hepatitis-B Associated Cryoglobulinemia Presenting as Pseudoleucocytosis
by: Yogesh Kr. Yadav, et al.
Published: (2011-07-01)

K topografiji rimske mestne četrti na današnjem Zgornjem Bregu v Ptuju
by: Iva Mikl
Published: (1965-05-01)

Trends in Liver Transplantation in Hepatitis C Virus–Infected Persons, United States
by: Ryan B. Perumpail, et al.
Published: (2016-03-01)

The nucleus accumbens in monkeys (Macaca fascicularis). III. Reversal learning.
by: Stern, C, et al.
Published: (1995)

Mild and Efficient Heterogeneous Hydrogenation of Nitroarenes Facilitated by a Pyrolytically Activated Dinuclear Ni(II)-Ce(III) Diimine Complex
by: Jessica Michalke, et al.
Published: (2022-08-01)

Prevalence of Hepatitis B and Hepatitis C Infections in a Tertiary Care Hospital, Telangana, India - Comparison of Pre-Pandemic and COVID-19 Pandemic times
by: C. Roopa, et al.
Published: (2022-12-01)

Rimski kastei v Zalogu pri Ljubljani
by: Iva Mikl Curk
Published: (1986-10-01)

Christoph Hinker: Flavia Solva vor der Stadtrechtsverleihung. Befunde und Funde aus der insula XL, 2006
by: Iva Mikl Curk
Published: (2007-01-01)

Sledovi rimskega zemljemerstva na Dravskem polju?
by: Iva Mikl Curk
Published: (1983-10-01)

Keltski sledovi v duhovni in materialni kulturi antičnega Poetovia
by: Iva Mikl Curk
Published: (1966-05-01)

Preučevanje rimske keramike kot vir za slovensko krajevno zgodovino
by: Iva Mikl Curk
Published: (1975-02-01)

Nekaj najdb sigilate iz Ptuja
by: Iva Mikl Curk
Published: (1981-11-01)